Track the Protea Biosciences Group, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 3 February 2016 (Attribution). Among the most active insiders: HARRIS LEONARD P. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Protea Biosciences Group, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Protea Biosciences Group, Inc. is a company focused on developing bioanalytical technologies and research services. It specializes in the analysis of biomolecules for applications in biopharmaceuticals and biomedical research.